Doxorubicin was intercalated into novel zirconium phosphate nano-platelets (ZrP). The obtained doxorubicin intercalated ZrP nano-platelets had an impressive 34.9% (w/w) drug loading. We used this material to deliver doxorubicin to breast cancer cells (MCF-7). Cellular studies with MCF-7cells showed higher uptake and cytotoxicity of doxorubicin loaded ZrP compared to free doxorubicin.
Fetching data from CrossRef. This may take some time to load.